We are live on ! Find out more
BCP

BlackBarn Capital Partners Portfolio holdings

AUM $1.19B
1-Year Est. Return 63.92%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+63.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.24B
AUM Growth
-$278M
Cap. Flow
+$44.4M
Cap. Flow %
3.57%
Top 10 Hldgs %
86.56%
Holding
24
New
8
Increased
6
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
VECO icon
Veeco
VECO
+$31.9M
2
NXPI icon
NXP Semiconductors
NXPI
+$13.3M
3
GBTG icon
American Express Global Business Travel
GBTG
+$12.4M
4
MH
McGraw Hill
MH
+$9.67M
5
PRVA icon
Privia Health
PRVA
+$6.42M

Top Sells

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$20.5M
2
DHC
Diversified Healthcare Trust
DHC
+$10.9M
3
ACLS icon
Axcelis
ACLS
+$7.76M
4
CCOI icon
Cogent Communications
CCOI
+$3.31M

Sector Composition

Rank Sector Weight
1 Miscellaneous 75.83%
2 Healthcare 11.9%
3 Technology 5.57%
4 Utilities 2.5%
5 Consumer Staples 2.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$520M 41.86%
800,000
-700,000
-47% -$476M
EWZ icon
2
PUT
iShares MSCI Brazil ETF
EWZ
$8.16B
$202M 16.21%
+5,250,000
New +$192M
RMD icon
3
PUT
ResMed
RMD
$34.7B
$89.8M 7.22%
400,000
– –
ROIV icon
4
Roivant Sciences
ROIV
$25.1B
$63.3M 5.09%
2,285,117
-799,183
-26% -$20.5M
AAL icon
5
PUT
American Airlines Group
AAL
$9.03B
$43M 3.46%
+4,000,000
New +$53M
VECO icon
6
Veeco
VECO
$2.71B
$33.9M 2.72%
+1,000,000
New +$31.9M
PRVA icon
7
Privia Health
PRVA
$2.66B
$32.6M 2.62%
1,585,000
+285,000
+22% +$6.42M
DHC
8
Diversified Healthcare Trust
DHC
$1.85B
$32M 2.57%
4,812,413
-1,717,727
-26% -$10.9M
NEE icon
9
NextEra Energy
NEE
$171B
$31.1M 2.5%
335,000
– –
MH
10
McGraw Hill
MH
$2.53B
$28.6M 2.3%
2,088,492
+688,492
+49% +$9.67M
PLTR icon
11
PUT
Palantir
PLTR
$448B
$25.6M 2.06%
+175,000
New +$26.8M
NIQ
12
NIQ Global Intelligence PLC
NIQ
$5.66B
$23.6M 1.9%
2,074,761
+274,761
+15% +$3.71M
WRBY icon
13
PUT
Warby Parker
WRBY
$3.09B
$21.1M 1.7%
1,000,000
-2,000,000
-67% -$49.6M
AMRX icon
14
Amneal Pharmaceuticals
AMRX
$6.11B
$20.5M 1.65%
1,650,000
+80,000
+5% +$1.07M
VKTX icon
15
Viking Therapeutics
VKTX
$3.75B
$20.2M 1.63%
621,450
+71,450
+13% +$2.3M
NXPI icon
16
NXP Semiconductors
NXPI
$56.4B
$11.8M 0.95%
+60,000
New +$13.3M
ABUS icon
17
Arbutus Biopharma
ABUS
$1B
$11.3M 0.91%
2,500,000
+650,000
+35% +$2.84M
GBTG icon
18
American Express Global Business Travel
GBTG
$4.95B
$11.2M 0.9%
+2,000,000
New +$12.4M
CCOI icon
19
Cogent Communications
CCOI
$486M
$9.42M 0.76%
500,000
-150,000
-23% -$3.31M
CCOI icon
20
PUT
Cogent Communications
CCOI
$486M
$9.42M 0.76%
+500,000
New +$11M
SEAT icon
21
Vivid Seats
SEAT
$67.7M
$2.96M 0.24%
+500,000
New +$3.26M
ACLS icon
22
Axcelis
ACLS
$3.57B
– –
-96,573
Closed -$7.76M
ELAN icon
23
PUT
Elanco Animal Health
ELAN
$12B
– –
-1,700,000
Closed -$38.5M
OSCR icon
24
PUT
Oscar Health
OSCR
$9.4B
– –
-1,300,000
Closed -$18.7M

Similar funds

BBP
Banco BTG Pactual Rio De Janeiro, Brazil $1.19B AUM 33.04% 1-Year Est. Return
CNBT
Canandaigua National Bank & Trust Canandaigua, New York $1.19B AUM
GA
GRS Advisors Chicago, Illinois $1.18B AUM 26.04% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.18B AUM 0.37% 1-Year Est. Return
AT
Arlington Trust Birmingham, Alabama $1.18B AUM 11.55% 1-Year Est. Return
RC
Randolph Company Cincinnati, Ohio $1.19B AUM 38.92% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.18B AUM 22.58% 1-Year Est. Return
TFA
Transamerica Financial Advisors St. Petersburg, Florida $1.18B AUM 31.24% 1-Year Est. Return

BlackBarn Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, BlackBarn Capital Partners held 24 positions worth $1.24B, down 18% from $1.52B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

BlackBarn Capital Partners deployed $44.4M of net new capital in Q1 2026, opening 8 new positions and adding to 6 existing holdings. Its largest new stake was Veeco: 1,000,000 shares worth $33.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 84% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Roivant Sciences, an estimated $20.5M trimmed.

  • BlackBarn Capital Partners's largest Q1 2026 buy was Veeco: 1,000,000 shares worth $33.9M.
  • BlackBarn Capital Partners added most to McGraw Hill in Q1 2026, an estimated $9.67M increase.
  • BlackBarn Capital Partners's biggest Q1 2026 reduction was Roivant Sciences, cutting an estimated $20.5M.
  • BlackBarn Capital Partners fully exited Axcelis in Q1 2026, selling an estimated $7.76M.
  • BlackBarn Capital Partners's ten largest holdings make up 87% of its $1.24B portfolio in Q1 2026.
  • BlackBarn Capital Partners opened 8 new positions and closed 3 in Q1 2026.
  • BlackBarn Capital Partners's portfolio value fell 18% quarter-over-quarter to $1.24B.

Based on BlackBarn Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.